Tarsus Pharmaceuticals (TARS) Return on Capital Employed Growth (1y) (2021 - 2026)
Tarsus Pharmaceuticals (TARS) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 2,400.00 |
| 10 | Tarsus Pharmaceuticals | 2.59 Bn | 2.49 Bn | 152.66 Mn | 1,910.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,910.00 |
| Dec 31, 2025 | 2,353.00 |
| Sep 30, 2025 | 2,327.00 |
| Jun 30, 2025 | 2,615.00 |
| Mar 31, 2025 | 2,789.00 |
| Dec 31, 2024 | 2,152.00 |
| Sep 30, 2024 | 1,014.00 |
| Jun 30, 2024 | 147.00 |
| Mar 31, 2024 | -2,582.00 |
| Dec 31, 2023 | -3,331.00 |
| Sep 30, 2023 | -2,844.00 |
| Jun 30, 2023 | -2,494.00 |
| Mar 31, 2023 | -774.00 |
| Dec 31, 2022 | -2,192.00 |
| Sep 30, 2022 | -2,203.00 |
| Jun 30, 2022 | -2,480.00 |
| Mar 31, 2022 | -1,710.00 |
| Dec 31, 2021 | 1,429.00 |